Coronary artery atherosclerosis is a condition where fatty deposits called plaques slowly build up inside the arteries that supply blood to your heart. Over time, these plaques narrow the arteries, restrict blood flow, and can eventually trigger a heart attack. It’s the underlying cause of coronary artery disease, which remains the leading cause of death worldwide. The process typically begins decades before symptoms appear, often starting as early as adolescence and progressing silently through middle age.
How Plaque Builds Up in Your Arteries
The inner lining of your arteries, called the endothelium, acts as a barrier between flowing blood and the artery wall. When that lining is damaged or stressed, the process of atherosclerosis begins. Areas where blood flow is turbulent, like bends and branch points in the coronary arteries, are especially vulnerable because the uneven flow weakens the lining’s ability to protect itself.
Once the lining is compromised, cholesterol particles (specifically LDL, the “bad” cholesterol) slip through and lodge in the artery wall. There, they undergo chemical changes that make them toxic to surrounding tissue. Your immune system responds by sending white blood cells to clean up the damage, but these cells gorge on the modified cholesterol and become bloated “foam cells” that pile up beneath the artery surface. This creates what’s known as a fatty streak, the earliest visible sign of atherosclerosis.
Over years and decades, layers of foam cells, dead cellular debris, calcium, and fibrous tissue accumulate into a structured plaque. A fibrous cap forms over the top, separating the plaque’s contents from the bloodstream. The artery gradually narrows, reducing the volume of blood that can pass through to your heart muscle.
Why Some People Develop It
Risk factors for coronary atherosclerosis fall into two categories: things you can’t change and things you can. Among the fixed risks, age is the most powerful. After age 40, men have roughly a 49% lifetime risk of developing coronary artery disease, while women have about a 32% risk. Men are affected more often and earlier than women, though the gap narrows after menopause. Family history matters too. Having a father or brother diagnosed before age 55, or a mother or sister before 65, significantly raises your own risk. Certain ethnic groups, including Black, Hispanic, Latino, and Southeast Asian populations, also carry higher rates of the disease.
The modifiable risks are where prevention efforts focus. High blood pressure damages artery walls through both mechanical and chemical stress, making it one of the strongest contributors. High cholesterol, particularly elevated LDL, feeds the plaque-building process directly. Diabetes accelerates atherosclerosis so aggressively that cardiovascular disease is the leading cause of death in diabetic patients. Obesity doubles the risk of coronary heart disease on its own and also promotes high blood pressure, high cholesterol, and diabetes simultaneously. Smoking doubles cardiovascular risk in current smokers, and even regular exposure to secondhand smoke raises risk by 25% to 30%. Diets high in trans fats worsen the picture by disrupting cholesterol levels, promoting inflammation, and increasing insulin resistance.
Symptoms at Different Stages
For most of its life, coronary atherosclerosis produces no symptoms at all. Plaques can grow for decades without you feeling anything, which is why the condition often catches people off guard. Symptoms typically don’t appear until a plaque has narrowed an artery enough to significantly limit blood flow, or until a plaque ruptures and triggers a sudden clot.
When blood flow to the heart muscle does become restricted, the most common symptom is chest pain or pressure, known as angina. This often shows up first during physical exertion or emotional stress, when your heart needs more oxygen than narrowed arteries can deliver. Other warning signs include shortness of breath, unusual fatigue, dizziness, cold sweats, heart palpitations, and nausea. Erectile dysfunction can also be an early signal of widespread atherosclerosis, since the smaller arteries supplying the penis are often affected before the larger coronary arteries show symptoms.
It’s worth noting that atherosclerosis rarely limits itself to the heart. The same process can affect arteries throughout the body. In the legs, it causes pain while walking that eases with rest. In the arteries feeding the brain, it can cause mini-strokes or full strokes. In the kidneys, it leads to high blood pressure and declining kidney function.
Stable Versus Dangerous Plaques
Not all plaques are equally threatening, and the size of a plaque doesn’t always predict the danger it poses. The critical distinction is between stable and unstable plaques.
Stable plaques tend to have thick fibrous caps, heavy calcification, and relatively small cores of fatty debris. They narrow the artery gradually and predictably. These are the plaques that cause chronic angina during exercise but rarely cause sudden heart attacks.
Unstable plaques, sometimes called vulnerable plaques, are a different story. They have large pools of fatty, necrotic debris covered by a dangerously thin fibrous cap, often less than 65 micrometers thick (thinner than a human hair). Immune cells called macrophages infiltrate these thin caps and weaken them by breaking down the structural proteins holding the cap together. When the cap ruptures, the plaque’s contents are exposed to the bloodstream, triggering a blood clot that can block the artery within minutes. This is a heart attack. Alarmingly, many heart attacks occur in arteries that were only moderately narrowed beforehand. The plaque wasn’t big enough to cause symptoms, but it was unstable enough to rupture.
A related mechanism called plaque erosion can also cause heart attacks. In erosion, the fibrous cap stays intact, but the endothelial cells on the plaque’s surface are lost, which still triggers clot formation. Erosion tends to happen in arteries with less severe narrowing than rupture, around 70% narrowing for ruptures versus 70% for erosion in one analysis.
How It’s Detected
Because atherosclerosis is silent for so long, detection often depends on testing rather than symptoms. Several tools are available, each suited to different situations.
A coronary artery calcium (CAC) score uses a quick, low-dose CT scan to measure calcified plaque in your coronary arteries. The result is an Agatston score: zero means very low risk, 1 to 99 indicates mildly increased risk, 100 to 299 reflects moderately increased risk, and 300 or above signals moderate to severe risk. This test is most useful for people at intermediate risk who need help deciding whether to start preventive treatment.
CT coronary angiography (CCTA) provides detailed images of both calcified and non-calcified plaque, along with the degree of artery narrowing. It’s significantly more sensitive than traditional stress tests. In pooled analyses, CCTA detected blockages with about 98% sensitivity compared to 67% for exercise stress tests and 73% for nuclear stress imaging. Its main strength is ruling out significant disease: a normal CCTA makes significant coronary blockages extremely unlikely.
Stress tests, while less sensitive, remain useful for assessing whether existing blockages are actually limiting blood flow to the heart during exertion. They’re often paired with imaging (echocardiography or nuclear imaging) to improve accuracy.
Blood markers add another layer of information. A high-sensitivity C-reactive protein (hs-CRP) test measures inflammation in the body. Levels below 1 mg/L suggest low cardiovascular risk, 1 to 3 mg/L indicates moderate risk, and above 3 mg/L points to elevated vascular risk. This test is most helpful alongside traditional cholesterol screening to refine your overall risk picture.
Treatment and Slowing Progression
Treatment for coronary atherosclerosis targets two goals: reducing the chance of a heart attack and relieving symptoms if they exist. For most people, this starts with lifestyle changes and medication.
Cholesterol-lowering therapy is the cornerstone of medical treatment. Current guidelines call for reducing LDL cholesterol by at least 50% in people with established coronary disease. American guidelines target an LDL below 70 mg/dL for high-risk patients, while European guidelines push even lower, aiming for below 55 mg/dL. When medication alone doesn’t reach these targets, additional drugs can be added to drive LDL lower. Reaching these aggressive targets doesn’t just slow plaque growth. It can actually shrink the non-calcified, more dangerous components of plaque.
Lifestyle intervention has measurable effects on plaque itself. In the DISCO-CT trial, patients who combined a controlled diet and exercise program with standard medication saw a meaningful reduction in non-calcified plaque volume (a drop of about 1.7% over the study period), significantly more than those on medication alone. While calcified plaque and fibrous tissue didn’t change much, reducing the soft, non-calcified component is important because that’s the material most associated with plaque instability.
When Procedures Are Needed
When atherosclerosis causes significant symptoms or threatens a large area of heart muscle, procedures to restore blood flow may be recommended. The two main options are stenting (percutaneous coronary intervention, or PCI) and bypass surgery (CABG).
For one or two blocked arteries, stenting is generally the first approach. A small mesh tube is placed inside the narrowed artery to hold it open, restoring blood flow. The procedure is minimally invasive, performed through a catheter inserted in the wrist or groin, and recovery is relatively quick.
Bypass surgery becomes the preferred option when the disease is more extensive. Patients with blockages in three or more arteries, disease in the left main coronary artery (which supplies a large portion of the heart), or significant disease combined with diabetes or weakened heart function generally do better with bypass surgery. The procedure uses blood vessels from elsewhere in the body to reroute blood around the blocked segments. It’s a major operation requiring weeks of recovery, but for complex disease patterns, it provides more durable and complete results than stenting.
For patients whose anatomy falls somewhere in between, scoring systems that rate the complexity of the blockages help guide the decision. Those with simpler anatomy can often choose between either approach with similar outcomes, while those with more complex patterns are steered toward bypass surgery. In all cases, procedures work alongside ongoing medication and lifestyle management, not as replacements for them.